From the ‡Drug & Disease Target Team, Division of Bioconvergence Analysis, Korea Basic Science Institute (KBSI), Cheongju 28119, Republic of Korea.
§Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Republic of Korea.
Mol Cell Proteomics. 2018 May;17(5):948-960. doi: 10.1074/mcp.RA117.000290. Epub 2018 Feb 1.
verctive ladder (OAB) syndrome is a condition that has four symptoms: urgency, urinary frequency, nocturia, and urge incontinence and negatively affects a patient's life. Recently, it is considered that the urinary bladder urothelium is closely linked to pathogenesis of OAB. However, the mechanisms of pathogenesis of OAB at the molecular level remain poorly understood, mainly because of lack of modern molecular analysis. The goal of this study is to identify a potential target protein that could act as a predictive factor for effective diagnosis and aid in the development of therapeutic strategies for the treatment of OAB syndrome. We produced OAB in a rat model and performed the first proteomic analysis on the mucosal layer (urothelium) of the bladders of sham control and OAB rats. The resulting data revealed the differential expression of 355 proteins in the bladder urothelium of OAB rats compared with sham subjects. Signaling pathway analysis revealed that the differentially expressed proteins were mainly involved in the inflammatory response and apoptosis. Our findings suggest a new target for accurate diagnosis of OAB that can provide essential information for the development of drug treatment strategies as well as establish criteria for screening patients in the clinical environment.
逼尿肌过度活动(OAB)综合征是一种具有四种症状(尿急、尿频、夜尿和急迫性尿失禁)的疾病,会对患者的生活产生负面影响。最近,人们认为膀胱尿路上皮与 OAB 的发病机制密切相关。然而,OAB 的发病机制在分子水平上的机制仍知之甚少,主要是因为缺乏现代分子分析。本研究的目的是确定一种潜在的靶蛋白,该蛋白可以作为有效诊断的预测因子,并有助于开发治疗 OAB 综合征的治疗策略。我们在大鼠模型中产生了 OAB,并对 sham 对照组和 OAB 大鼠的膀胱黏膜层(尿路上皮)进行了首次蛋白质组学分析。结果数据显示,与 sham 组相比,OAB 大鼠的膀胱尿路上皮中有 355 种蛋白差异表达。信号通路分析表明,差异表达的蛋白主要参与炎症反应和细胞凋亡。我们的研究结果为 OAB 的准确诊断提供了一个新的靶点,可为药物治疗策略的制定提供必要的信息,并为临床环境中的患者筛选建立标准。